[Comparative toxic and therapeutic effects of adriamycin and bleomycin in malignant lymphoma (author's transl)].
D000328:Adult; D000505:Alopecia / Q000139:chemically induced; D001761:Bleomycin / Q000009:adverse effects / Q000627:therapeutic use*; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D012075:Remission, Spontaneous; D013280:Stomatitis / Q000139:chemically induced
D001761:Bleomycin; D004317:Doxorubicin
Confronto dell'attività terapeutica e tossicologica fra adriamicina e bleomicina nei linfomi maligni